Cargando…
Establishment and validation of an immunodiagnostic model for prediction of breast cancer
Serum autoantibodies that react with tumor-associated antigens (TAAs) can be used as potential biomarkers for diagnosis of cancer. This study aims to evaluate the immunodiagnostic value of 11 anti-TAAs autoantibodies for detection of breast cancer (BC) and establish a diagnostic model for distinguis...
Autores principales: | Qiu, Cuipeng, Wang, Peng, Wang, Bofei, Shi, Jianxiang, Wang, Xiao, Li, Tiandong, Qin, Jiejie, Dai, Liping, Ye, Hua, Zhang, Jianying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959442/ https://www.ncbi.nlm.nih.gov/pubmed/32002291 http://dx.doi.org/10.1080/2162402X.2019.1682382 |
Ejemplares similares
-
Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021) -
Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021) -
Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019) -
Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays
por: Yang, Qian, et al.
Publicado: (2020) -
Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes
por: Wang, Keyan, et al.
Publicado: (2020)